Integrating Diagnostic and Interventional MRI for the Molecular Characterization of Prostate Cancer. 5th Interventional MRI Symposium.(2004).
MRI For The Molecular Characterization Of Prostate Cancer Integrating Diagnostic And Interventional MRI For The Molecular Characterization Of Prostate Cancer. 5th Interventional MRI Symposium. 26.(2004).
An MRI System for Guidance and Monitoring of Transrectal Prostate Interventions in a 1 5T Scanner. Radiological Society of North America, 89th Scientific Assembly.(2003).
Technique and Accuracy of a Clinical System for Transrectal Intraprostatic Needle Placement in a Standard 1 5T MRI Scanner. American Urological Association.(2004).
Transrectal Prostate Biopsy and Fiducial Marker Placement in a Standard 1 5T MRI Scanner. Annual Meeting of International Society of Magnetic Resonance in Medicine (ISMRM).(2004).
An Interventional MRI Technique for the Molecular Characterization of Intra-Prostatic Dynamic Contrast Enhancement. Molecular Imaging. 4 No 1, 63-66.(2005).
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. British Journal of Urology international. 101, 181–185.(2007).
Simultaneous integrated boost of biopsy proven and MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study. Radiation Oncology. 2, 36.(2007).
Transrectal prostate biopsy and fiducial marker placement in a standard 1 5T magnetic resonance imaging scanner. The Journal of Urology. 175, 113–120.(2006).